180 related articles for article (PubMed ID: 35631342)
1. Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery.
Panoutsopoulou E; Zbytovská J; Vávrová K; Paraskevopoulos G
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631342
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of imiquimod skin penetration.
Telò I; Pescina S; Padula C; Santi P; Nicoli S
Int J Pharm; 2016 Sep; 511(1):516-523. PubMed ID: 27452419
[TBL] [Abstract][Full Text] [Related]
3. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
Pescina S; Garrastazu G; Del Favero E; Rondelli V; Cantù L; Padula C; Santi P; Nicoli S
Eur J Pharm Sci; 2018 Dec; 125():223-231. PubMed ID: 30316975
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod.
Lapteva M; Mignot M; Mondon K; Möller M; Gurny R; Kalia YN
Eur J Pharm Biopharm; 2019 Sep; 142():553-562. PubMed ID: 30641138
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Enhanced Skin Permeation and Retention of Imiquimod Loaded in β-Cyclodextrin Nanosponge Hydrogel.
Argenziano M; Haimhoffer A; Bastiancich C; Jicsinszky L; Caldera F; Trotta F; Scutera S; Alotto D; Fumagalli M; Musso T; Castagnoli C; Cavalli R
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30897794
[TBL] [Abstract][Full Text] [Related]
6. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
Amarji B; Garg NK; Singh B; Katare OP
J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326
[TBL] [Abstract][Full Text] [Related]
7. Nanoformulations for dermal delivery of imiquimod: The race of "soft" against "hard".
Petrová E; Chvíla S; Balouch M; Štěpánek F; Zbytovská J
Int J Pharm; 2023 Dec; 648():123577. PubMed ID: 37931726
[TBL] [Abstract][Full Text] [Related]
8. Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach.
Kim S; Abdella S; Abid F; Afinjuomo F; Youssef SH; Holmes A; Song Y; Vaidya S; Garg S
Int J Nanomedicine; 2023; 18():1007-1029. PubMed ID: 36855538
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour.
Sharma A; Sharma D; Baldi A; Jyoti K; Chandra R; Madan J
J Microencapsul; 2019 Dec; 36(8):759-774. PubMed ID: 31587598
[TBL] [Abstract][Full Text] [Related]
10. Microemulsions vs chitosan derivative-coated microemulsions for dermal delivery of 8-methoxypsoralen.
Wu JY; Li YJ; Liu TT; Ou G; Hu XB; Tang TT; Wang JM; Liu XY; Xiang DX
Int J Nanomedicine; 2019; 14():2327-2340. PubMed ID: 31015760
[TBL] [Abstract][Full Text] [Related]
11. Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers.
Azin M; Ngo KH; Hojanazarova J; Demehri S
JID Innov; 2023 Nov; 3(6):100221. PubMed ID: 37731472
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
13. Ionic Liquid-Enabled Topical Delivery of Immunomodulators.
Zhao Z; Tanner EEL; Kim J; Ibsen K; Gao Y; Mitragotri S
ACS Biomater Sci Eng; 2021 Jun; 7(6):2783-2790. PubMed ID: 33983704
[TBL] [Abstract][Full Text] [Related]
14. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
[TBL] [Abstract][Full Text] [Related]
15. Delivery of oat-derived phytoceramides into the stratum corneum of the skin using nanocarriers: Formulation, characterization and in vitro and ex-vivo penetration studies.
Tessema EN; Gebre-Mariam T; Paulos G; Wohlrab J; Neubert RHH
Eur J Pharm Biopharm; 2018 Jun; 127():260-269. PubMed ID: 29501672
[TBL] [Abstract][Full Text] [Related]
16. An Alternative Device for the Topical Treatment of Oral Cancer: Development and Ex-Vivo Evaluation of Imiquimod-Loaded Polysaccharides Formulations.
Remiro PFR; Nagahara MHT; Ghezzi M; Filippini A; Demurtas A; Pescina S; Santi P; Padula C; Moraes ÂM; Nicoli S
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559066
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical Assessment and Irritation Potential of Microemulsions and Conventional Systems Containing Oil from Syagrus cearensis for Topical Delivery of Amphotericin B Using Alternative Methods.
Sousa GD; Kishishita J; Aquino KAS; Presgrave OAF; Leal LB; Santana DP
AAPS PharmSciTech; 2017 Jul; 18(5):1833-1842. PubMed ID: 27834055
[TBL] [Abstract][Full Text] [Related]
18. Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin.
Telò I; Favero ED; Cantù L; Frattini N; Pescina S; Padula C; Santi P; Sonvico F; Nicoli S
Mol Pharm; 2017 Oct; 14(10):3281-3289. PubMed ID: 28825487
[TBL] [Abstract][Full Text] [Related]
19. Lecithin-based microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterizations, and in vitro release and penetration studies.
Sahle FF; Metz H; Wohlrab J; Neubert RH
Pharm Res; 2013 Feb; 30(2):538-51. PubMed ID: 23135817
[TBL] [Abstract][Full Text] [Related]
20. Potential of Non-aqueous Microemulsions to Improve the Delivery of Lipophilic Drugs to the Skin.
Carvalho VF; de Lemos DP; Vieira CS; Migotto A; Lopes LB
AAPS PharmSciTech; 2017 Jul; 18(5):1739-1749. PubMed ID: 27757922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
